- Home
- BNT vs AXSM Comparison
BNT vs AXSM Comparison
Compare BNT & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNT | AXSM |
|---|---|---|
| Founded | 2020 | 2012 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 11.2B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BNT | AXSM |
|---|---|---|
| Price | $42.23 | $205.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $211.12 |
| AVG Volume (30 Days) | 9.8K | ★ 648.7K |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.65% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $57.24 |
| Revenue Next Year | N/A | $55.88 |
| P/E Ratio | $19.14 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $40.06 | $112.90 |
| 52 Week High | $74.16 | $260.19 |
Technical Indicators
Market Signals| Indicator | BNT | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 39.74 | 38.09 |
| Support Level | $41.95 | $206.94 |
| Resistance Level | $46.81 | $236.26 |
| Average True Range (ATR) | 0.70 | 6.61 |
| MACD | -0.30 | -0.30 |
| Stochastic Oscillator | 13.87 | 13.10 |
Price Performance
Historical ComparisonAbout BNT Brookfield Wealth Solutions Ltd.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. The Company's reporting segments are Annuities, P&C, Life Insurance and Corporate and Other. Majority revenue is generated from Annuities segment followed by P&C.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.